National Bank of Canada’s Profound Medical PROF Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $956K | Buy |
161,179
+24,053
| +18% | +$143K | ﹤0.01% | 1040 |
|
|
2025
Q1 | $667K | Buy |
137,126
+10,618
| +8% | +$51.6K | ﹤0.01% | 1031 |
|
|
2024
Q4 | $951K | Buy |
126,508
+4,671
| +4% | +$35.1K | ﹤0.01% | 1042 |
|
|
2024
Q3 | $970K | Sell |
121,837
-6,433
| -5% | -$51.2K | ﹤0.01% | 965 |
|
|
2024
Q2 | $1.07M | Buy |
128,270
+241
| +0.2% | +$2.01K | ﹤0.01% | 934 |
|
|
2024
Q1 | $960K | Buy |
128,029
+1,301
| +1% | +$9.75K | ﹤0.01% | 985 |
|
|
2023
Q4 | $1.01M | Sell |
126,728
-1,413
| -1% | -$11.3K | ﹤0.01% | 1012 |
|
|
2023
Q3 | $1.21M | Buy |
128,141
+2,458
| +2% | +$23.2K | ﹤0.01% | 973 |
|
|
2023
Q2 | $1.6M | Sell |
125,683
-1,644
| -1% | -$20.9K | ﹤0.01% | 923 |
|
|
2023
Q1 | $1.17M | Sell |
127,327
-772,150
| -86% | -$7.09M | ﹤0.01% | 907 |
|
|
2022
Q4 | $9.83M | Buy |
899,477
+2,749
| +0.3% | +$30.1K | 0.03% | 393 |
|
|
2022
Q3 | $3.74M | Buy |
896,728
+778,386
| +658% | +$3.24M | 0.02% | 539 |
|
|
2022
Q2 | $840K | Buy |
118,342
+4,727
| +4% | +$33.6K | ﹤0.01% | 909 |
|
|
2022
Q1 | $1.02M | Buy |
113,615
+33,955
| +43% | +$303K | ﹤0.01% | 935 |
|
|
2021
Q4 | $722K | Buy |
+79,660
| New | +$722K | ﹤0.01% | 999 |
|